The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Ceramide glycosylation potentiates cellular multidrug resistance
Abstract
Ceramide glycosylation, through glucosylceramide synthase (GCS), allows cellular escape from ceramide‐induced programmed cell death. This glycosylation event confers cancer cell resistance to cytotoxic anticancer agents [Liu, Y. Y., Han, T. Y., Giuliano, A. E., and M. C. Cabot. (1999) J. Biol. Chem . 274, 1140–1146]. We previously found that glucosylce‐ramide, the glycosylated form of ceramide, accumulates in adriamycin‐resistant breast carcinoma cells, in vinblastine‐resistant epithelioid carcinoma cells, and in tumor specimens from patients showing poor response to chemotherapy. Here we show that multidrug resistance can be increased over baseline and then totally reversed in human breast cancer cells by GCS gene targeting. In adriamycin‐resistant MCF‐7‐AdrR cells, transfection of GCS upgraded multidrug resistance, whereas transfection of GCS antisense markedly restored cellular sensitivity to anthracyclines, Vinca alkaloids, taxanes, and other anticancer drugs. Sensitivity to the various drugs by GCS antisense transfection increased 7‐ to 240‐fold and was consistent with the resumption of ceramide‐caspase‐apoptotic signaling. GCS targeting had little influence on cellular sensitivity to either 5‐FU or cisplatin, nor did it modify P‐glyco‐protein expression or rhodamine‐123 efflux. GCS anti‐sense transfection did enhance rhodamine‐123 uptake compared with parent MCF‐7‐AdrR cells. This study reveals that GCS is a novel mechanism of multidrug resistance and positions GCS antisense as an innovative force to overcome multidrug resistance in cancer chemotherapy.—Liu, Y.‐Y., Han, T.‐Y., Giuliano, A. E., and Cabot, M. C. Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J. 15, 719‐730 (2001)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., & Lipton, S. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7162 · Cited by 1,958
Functions of Ceramide in Coordinating Cellular Responses to Stress
Hannun, Y. A. (1996) · Science · doi:10.1126/science.274.5294.1855 · Cited by 1,617
Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., & Kolesnick, R. (1995) · Cell · doi:10.1016/0092-8674(95)90429-8 · Cited by 826
REGULATION OF CERAMIDE PRODUCTION AND APOPTOSIS
Kolesnick, R. N., & Krönke, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.643 · Cited by 803
Batist, G., Tulpule, A., Sinha, B. K., Katki, A. G., Myers, C. E., & Cowan, K. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66748-1 · Cited by 789
Caveolae, DIGs, and the dynamics of sphingolipid—cholesterol microdomains
Harder, T., & Simons, K. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80030-0 · Cited by 779
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
A vital role for glycosphingolipid synthesis during development and differentiation
Yamashita, T., Wada, R., Sasaki, T., Deng, C., Bierfreund, U., Sandhoff, K., & Proia, R. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9142 · Cited by 505
Riordan, J. R., & Ling, V. W. T. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86370-6 · Cited by 362
Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells
Lavie, Y., Cao, H.-T., Bursten, S. L., Giuliano, A. E., & Cabot, M. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19530 · Cited by 340
Self-citationIchikawa, S., Sakiyama, H., Suzuki, G., Hidari, K. I., & Hirabayashi, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4638 · Cited by 315
Iwabuchi, K., Yamamura, S., Prinetti, A., Handa, K., & Hakomori, S.-I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9130 · Cited by 300
Luberto, C., & Hannun, Y. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14550 · Cited by 297
Fairchild, C. R., Ivy, S. P., Kao-Shan, C. S., et al. (1987) · PubMed · Cited by 297
Cowan, K. H., Batist, G., Tulpule, A., Sinha, B. K., & Myers, C. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9328 · Cited by 293
Lavie, Y., Cao, H.-T., Volner, A., Lucci, A., Han, T.-Y., Geffen, V., Giuliano, A. E., & Cabot, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1682 · Cited by 284
Self-citationLiu, Y.-Y., Han, T.-Y., Giuliano, A. E., & Cabot, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.1140 · Cited by 269
Self-citationFerté, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01046.x · Cited by 194
Clinical multidrug resistance in cancer: A multifactorial problem
Lehnert, M. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00069-x · Cited by 176
Glucosylceramide: a marker for multiple-drug resistant cancers.
Lucci, A., Cho, W. I., Han, T., Giuliano, A. E., Morton, D. L., & Cabot, M. C. (1998) · PubMed · Cited by 168
Self-citationCancer-Associated Glycosphingolipid Antigens: Their Structure, Organization, and Function
Hakomori, S.-I. (1998) · Cells Tissues Organs · doi:10.1159/000046451 · Cited by 163
p53-dependent ceramide response to genotoxic stress.
Dbaibo, G. S., Pushkareva, M. Y., Rachid, R. A., Alter, N., Smyth, M. J., Obeid, L. M., & Hannun, Y. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1180 · Cited by 162
Cell Cycle Arrest Induced by an Inhibitor of Glucosylceramide Synthase
Rani, S. C. S., Abe, A., Chang, Y., Rosenzweig, N., Saltiel, A. R., Radin, N. S., & Shayman, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2859 · Cited by 159
Peterson, R. H. F., Meyers, M. B., Spengler, B. A., et al. (1983) · PubMed · Cited by 147
Liu, Y., Han, T.-Y., Giuliano, A. E., Hansen, N. M., & Cabot, M. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7138 · Cited by 129
Self-citationCha, H. H., Cram, E. J., Wang, E. C., Huang, A. J., Kasler, H. G., & Firestone, G. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.1998 · Cited by 125
Fairchild, C. R., Moscow, J. A., O’Brien, E., et al. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11028-6 · Cited by 107
Inokuchi, J., Jimbo, M., Momosaki, K., Shimeno, H., NAGAMATSU, A., & Radin, N. S. (1990) · PubMed · Cited by 100
Recent Advances in the Biochemistry of Sphingolipidoses
Kolter, T., & Sandhoff, K. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00138.x · Cited by 88
Glucosylceramide Synthase Inhibitor Inhibits the Action of Nerve Growth Factor in PC12 Cells
Mutoh, T., Tokuda, A., Inokuchi, J., & Kuriyama, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26001 · Cited by 81
Liu, Y. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4649 · Cited by 76
Self-citationGlucosylceramides stimulate murine epidermal hyperproliferation.
Marsh, N. L., Elias, P. M., & Holleran, W. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117997 · Cited by 70
Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase
Nicholson, K. M., Quinn, D. M., Kellett, G. L., & Warr, J. R. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690711 · Cited by 68
The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation
Cabot, M. C., Han, T.-Y., & Giuliano, A. E. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00744-3 · Cited by 56
Self-citationBirklé, S., Gao, L., Zeng, G., & Yu, R. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740547.x · Cited by 48
Stimulation of liver growth and DNA synthesis by glucosylceramide
Datta, S. C., & Radin, N. S. (1988) · Lipids · doi:10.1007/bf02535529 · Cited by 45
Stein, U., Walther, W., Lemm, M., Naundorf, H., & Fichtner, I. (1997) · International Journal of Cancer · Cited by 41
Expression of Q227L-Gα s in MCF-7 human breast cancer cells inhibits tumorigenesis
Chen, J., Bander, J. A., Santore, T. A., Chen, Y., Ram, P. T., Smit, M. J., & Iyengar, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2648 · Cited by 36
Effects of the glucosphingolipid synthesis inhibitor, PDMP, on lysosomes in cultured cells.
Rosenwald, A., & Pagano, R. E. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39966-1 · Cited by 26
Cited by
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Biologically active sphingolipids in cancer pathogenesis and treatment
Ogretmen, B., & Hannun, Y. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1411 · Cited by 1,213
Ceramide in apoptosis: an overview and current perspectives
Pettus, B. J., Chalfant, C. E., & Hannun, Y. A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00331-1 · Cited by 788
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Merrill, A. H. (2011) · Chemical Reviews · doi:10.1021/cr2002917 · Cited by 785
Metadata
- Authors
- LIU, Y., HAN, T., GIULIANO, A. E., & CABOT, M. C.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-03
- Volume
- 15
- Issue
- 3
- Pages
- 719-730
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2048217586
- Cited by
- 303
- References
- 42
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.